249 related articles for article (PubMed ID: 28064112)
1. Ultra-short screening instruments for major depressive episode and generalized anxiety disorder in epilepsy: The NDDIE-2 and the GAD-SI.
Micoulaud-Franchi JA; Bartolomei F; McGonigal A
J Affect Disord; 2017 Mar; 210():237-240. PubMed ID: 28064112
[TBL] [Abstract][Full Text] [Related]
2. Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample.
Micoulaud-Franchi JA; Lagarde S; Barkate G; Dufournet B; Besancon C; Trébuchon-Da Fonseca A; Gavaret M; Bartolomei F; Bonini F; McGonigal A
Epilepsy Behav; 2016 Apr; 57(Pt A):211-216. PubMed ID: 26994447
[TBL] [Abstract][Full Text] [Related]
3. Examining brief and ultra-brief anxiety and depression screening methods in a real-world epilepsy clinic sample.
Munger Clary HM; Wan M; Conner K; Brenes GA; Kimball J; Kim E; Duncan P; Snively BM
Epilepsy Behav; 2021 May; 118():107943. PubMed ID: 33839449
[TBL] [Abstract][Full Text] [Related]
4. One step closer to a global tool for rapid screening of major depression in epilepsy: validation of the French NDDI-E.
Micoulaud-Franchi JA; Barkate G; Trébuchon-Da Fonseca A; Vaugier L; Gavaret M; Bartolomei F; McGonigal A
Epilepsy Behav; 2015 Mar; 44():11-6. PubMed ID: 25597527
[TBL] [Abstract][Full Text] [Related]
5. Screening for depression in youth with epilepsy: Psychometric analysis of NDDI-E-Y and NDDI-E in a French population.
Viellard M; Villeneuve N; Milh M; Lépine A; Micoulaud-Franchi JA; McGonigal A
Epilepsy Behav; 2019 Sep; 98(Pt A):19-26. PubMed ID: 31299528
[TBL] [Abstract][Full Text] [Related]
6. Validation of the generalized anxiety disorder-7 in people with epilepsy: a MEPSY study.
Seo JG; Cho YW; Lee SJ; Lee JJ; Kim JE; Moon HJ; Park SP
Epilepsy Behav; 2014 Jun; 35():59-63. PubMed ID: 24798411
[TBL] [Abstract][Full Text] [Related]
7. Evaluating quality of life in epilepsy: The role of screening for adverse drug effects, depression, and anxiety.
Micoulaud-Franchi JA; Bartolomei F; Duncan R; McGonigal A
Epilepsy Behav; 2017 Oct; 75():18-24. PubMed ID: 28818810
[TBL] [Abstract][Full Text] [Related]
8. Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study.
Butnoriene J; Steibliene V; Saudargiene A; Bunevicius A
BMC Psychiatry; 2018 Jan; 18(1):5. PubMed ID: 29310620
[TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of the Lithuanian version of the NDDI-E in persons with epilepsy and suicidal ideation.
Puteikis K; Mameniškienė R
Epilepsy Behav; 2022 Nov; 136():108913. PubMed ID: 36155364
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Russian version of neurological disorders depression inventory for epilepsy (NDDI-E).
Zinchuk M; Kustov G; Pashnin E; Gersamia A; Rider F; Yakovlev A; Guekht A
Epilepsy Behav; 2020 Dec; 113():107549. PubMed ID: 33246233
[TBL] [Abstract][Full Text] [Related]
11. Screening for epilepsy-specific anxiety symptoms: French validation of the EASI.
Micoulaud-Franchi JA; Kotwas I; Arthuis M; Soncin L; Rontani P; Daquin G; Cermolacce M; Bartolomei F; McGonigal A
Epilepsy Behav; 2022 Mar; 128():108585. PubMed ID: 35180578
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) Serbian version.
Ristić AJ; Pjevalica J; Trajković G; Parojčić A; Mihajlović A; Vojvodić N; Baščarević V; Popović T; Janković S; Sokić D
Epilepsy Behav; 2016 Apr; 57(Pt A):1-4. PubMed ID: 26900772
[TBL] [Abstract][Full Text] [Related]
13. Reliability and validity of the Taiwanese version of the Neurological Disorders Depression Inventory for Epilepsy (Tw-NDDI-E).
Shih YC; Chou CC; Lu YJ; Chou YH; Yu HY
Seizure; 2020 Oct; 81():53-57. PubMed ID: 32745948
[TBL] [Abstract][Full Text] [Related]
14. Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI).
de Oliveira GN; Lessa JM; Gonçalves AP; Portela EJ; Sander JW; Teixeira AL
Epilepsy Behav; 2014 May; 34():50-4. PubMed ID: 24681386
[TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of the Korean version of the Neurological Disorders Depression Inventory for Epilepsy (K-NDDI-E).
Ko PW; Hwang J; Lim HW; Park SP
Epilepsy Behav; 2012 Dec; 25(4):539-42. PubMed ID: 23153718
[TBL] [Abstract][Full Text] [Related]
16. Validation of rapid suicidality screening in epilepsy using the NDDIE.
Mula M; McGonigal A; Micoulaud-Franchi JA; May TW; Labudda K; Brandt C
Epilepsia; 2016 Jun; 57(6):949-55. PubMed ID: 27012840
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China.
Tong X; An D; Lan L; Zhou X; Zhang Q; Xiao F; Park SP; Kanemoto K; Kanner AM; Zhou D
Epilepsy Behav; 2015 Jun; 47():6-10. PubMed ID: 26004785
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Neurological Disorders Depression Inventory for Epilepsy (NDDIE) as a rapid suicidality screening tool in Chinese people with epilepsy.
Li Q; Zhu LN; Wang HJ; Lin X; Xu D; Chen D; Zhang Y; Liu L
Epilepsy Behav; 2019 May; 94():216-221. PubMed ID: 30974350
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Generalized Anxiety Disorder-7 (GAD-7) among Chinese people with epilepsy.
Tong X; An D; McGonigal A; Park SP; Zhou D
Epilepsy Res; 2016 Feb; 120():31-6. PubMed ID: 26709880
[TBL] [Abstract][Full Text] [Related]
20. Not always that EASI: Validating the Russian version of the epilepsy anxiety survey instrument and its brief counterpart.
Zinchuk M; Kustov G; Pashnin E; Gersamia A; Rider F; Voinova N; Popova S; Sviatskaia E; Yakovlev A; Guekht A
Epilepsy Behav; 2022 Aug; 133():108801. PubMed ID: 35753109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
